Towards Healthcare
CDMO Services for Pharma and Biotech Market Expands in 2025 as Small Molecules...

CDMO Services for Pharma and Biotech Market Leads North America with 44.1% in 2024

Based on forecasts, the CDMO services for pharma and biotech market is expanding due to increasing outsourcing as well as rising cancer treatment approaches. North America led the market due to the presence of well-developed industries.     

  • Last Updated: 01 November 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

The CDMO Services for Pharma and Biotech Market (2024–2034), driven by innovation in biologics, personalized medicine, and global outsourcing trends.

North America is currently leading the CDMO services for pharma and biotech market due to the presence of well-developed industries.

The CDMO services for pharma and biotech market includes six segments such as by service type, Shape, Pictureby molecule type,Shape, Picture Shape, Picture by phase, by end user, by therapeutic area, and by region.

Some key players include Lonza Group AG, Catalent Inc., Thermo Fisher Scientific (Patheon), and WuXi AppTec.

Key trends include rising accessibility and availability of Pb-212 generator platform and alpha isotopes, and innovation in biosimilars.

Oncology is the therapeutic area that dominates the market.

Increasing outsourcing is the factor that drives the market.

DCAT Value Chain Insights, Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.